Use of the investigational non-opioid analgesic resiniferatoxin appeared to improve pain control in patients with advanced ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the publication of its study investigating Caldolor® (intravenous ibuprofen) in older patients. The ...

An experimental drug developed by researchers at Duke University could be a key component in solving the nation’s opioid ...

To assess the safety and efficacy of IV ibuprofen in older adults, researchers conducted a post hoc subgroup analysis with data from 4 prospective clinical studies.

The Washington Post reports on new tools that could lead to treatments for Parkinson's, Alzheimer's, and other neurodegenerative diseases. Other science and research news is on childhood lead exposure ...

An experimental drug developed at Duke University School of Medicine could offer powerful pain relief without the dangerous ...

Chronic pain affects more than 50 million Americans and remains one of the most difficult conditions to treat safely and effectively. While opioids have lo | Drug Discovery And Development ...

A groundbreaking study reveals the efficacy of SBI-810, a non-opioid pain reliever, in mice. This novel compound targets ...

Acute Pain Services provided safe and effective analgesia for pediatric patients who underwent orthopedic procedures.